Manufacturer and distributor Medline and sleep apnea interface maker Bleep LLC have partnered to co-brand and distribute Bleep’s DreamPort Sleep Solution to the hospital and post-acute care markets.
“Our partnership with Bleep strengthens Medline’s portfolio of patient-centered solutions linked to improved outcomes,” says Tim Finnigan, respiratory division president at Medline, in a release. “This particular CPAP solution simplifies care, improving efficiency and experience for the healthcare staff while enhancing consistency of care.”
Stuart Heatherington, founder and CEO of Bleep, says, “We couldn’t be more excited to work together with Medline to accomplish their goal of ‘Advancing the Health of Healthcare.’ We value Medline’s commitment to customers, organizational strength, and dedication to improving patient outcomes, and we look forward to our future growth together.”
The patented DreamPort Sleep Solution uses hypoallergenic medical-grade adhesive strips to reduce the risk of leak and hold the DreamPorts in place under the nose for optimized comfort. They do not leave marks on the face and don’t constrict movement.